294 related articles for article (PubMed ID: 12761336)
21. Interaction of marine toxin dolastatin 10 with porcine brain tubulin: competitive inhibition of rhizoxin and phomopsin A binding.
Li Y; Kobayashi H; Hashimoto Y; Shirai R; Hirata A; Hayashi K; Hamada Y; Shioiri T; Iwasaki S
Chem Biol Interact; 1994 Dec; 93(3):175-83. PubMed ID: 7923438
[TBL] [Abstract][Full Text] [Related]
22. Antimitotic antifungal compound benomyl inhibits brain microtubule polymerization and dynamics and cancer cell proliferation at mitosis, by binding to a novel site in tubulin.
Gupta K; Bishop J; Peck A; Brown J; Wilson L; Panda D
Biochemistry; 2004 Jun; 43(21):6645-55. PubMed ID: 15157098
[TBL] [Abstract][Full Text] [Related]
23. Antineoplastic agents 337. Synthesis of dolastatin 10 structural modifications.
Pettit GR; Srirangam JK; Barkoczy J; Williams MD; Durkin KP; Boyd MR; Bai R; Hamel E; Schmidt JM; Chapuis JC
Anticancer Drug Des; 1995 Oct; 10(7):529-44. PubMed ID: 7495477
[TBL] [Abstract][Full Text] [Related]
24. A synthetic dolastatin 10 analogue suppresses microtubule dynamics, inhibits cell proliferation, and induces apoptotic cell death.
Gajula PK; Asthana J; Panda D; Chakraborty TK
J Med Chem; 2013 Mar; 56(6):2235-45. PubMed ID: 23445405
[TBL] [Abstract][Full Text] [Related]
25. Interactions of antimitotic peptides and depsipeptides with tubulin.
Hamel E
Biopolymers; 2002; 66(3):142-60. PubMed ID: 12385035
[TBL] [Abstract][Full Text] [Related]
26. Development of Potent Microtubule Targeting Agent by Structural Simplification of Natural Diazonamide.
Kalnins T; Vitkovska V; Kazak M; Zelencova-Gopejenko D; Ozola M; Narvaiss N; Makrecka-Kuka M; Domračeva I; Kinens A; Gukalova B; Konrad N; Aav R; Bonato F; Lucena-Agell D; Díaz JF; Liepinsh E; Suna E
J Med Chem; 2024 Jun; 67(11):9227-9259. PubMed ID: 38833507
[TBL] [Abstract][Full Text] [Related]
27. Antimitotic and tubulin-interacting properties of vinflunine, a novel fluorinated Vinca alkaloid.
Kruczynski A; Barret JM; Etiévant C; Colpaert F; Fahy J; Hill BT
Biochem Pharmacol; 1998 Mar; 55(5):635-48. PubMed ID: 9515574
[TBL] [Abstract][Full Text] [Related]
28. Suppression of microtubule dynamics by binding of cemadotin to tubulin: possible mechanism for its antitumor action.
Jordan MA; Walker D; de Arruda M; Barlozzari T; Panda D
Biochemistry; 1998 Dec; 37(50):17571-8. PubMed ID: 9860873
[TBL] [Abstract][Full Text] [Related]
29. Interaction of dolastatin 10 with bovine brain tubulin.
Ludueña RF; Roach MC; Prasad V; Pettit GR
Biochem Pharmacol; 1992 Feb; 43(3):539-43. PubMed ID: 1540211
[TBL] [Abstract][Full Text] [Related]
30. Effects of antimitotic agents on tubulin-nucleotide interactions.
Correia JJ
Pharmacol Ther; 1991 Nov; 52(2):127-47. PubMed ID: 1818332
[TBL] [Abstract][Full Text] [Related]
31. Sustained intracellular retention of dolastatin 10 causes its potent antimitotic activity.
Verdier-Pinard P; Kepler JA; Pettit GR; Hamel E
Mol Pharmacol; 2000 Jan; 57(1):180-7. PubMed ID: 10617693
[TBL] [Abstract][Full Text] [Related]
32. HMBA depolymerizes microtubules, activates mitotic checkpoints and induces mitotic block in MCF-7 cells by binding at the colchicine site in tubulin.
Chatterji BP; Banerjee M; Singh P; Panda D
Biochem Pharmacol; 2010 Jul; 80(1):50-61. PubMed ID: 20302847
[TBL] [Abstract][Full Text] [Related]
33. Dietary antioxidant curcumin inhibits microtubule assembly through tubulin binding.
Gupta KK; Bharne SS; Rathinasamy K; Naik NR; Panda D
FEBS J; 2006 Dec; 273(23):5320-32. PubMed ID: 17069615
[TBL] [Abstract][Full Text] [Related]
34. Derivatives of 5,6-diphenylpyridazin-3-one: synthetic antimitotic agents which interact with plant and mammalian tubulin at a new drug-binding site.
Batra JK; Powers LJ; Hess FD; Hamel E
Cancer Res; 1986 Apr; 46(4 Pt 2):1889-93. PubMed ID: 3948171
[TBL] [Abstract][Full Text] [Related]
35. Interaction of dolastatin 10 with tubulin: induction of aggregation and binding and dissociation reactions.
Bai R; Taylor GF; Schmidt JM; Williams MD; Kepler JA; Pettit GR; Hamel E
Mol Pharmacol; 1995 May; 47(5):965-76. PubMed ID: 7746283
[TBL] [Abstract][Full Text] [Related]
36. Interactions of the sponge-derived antimitotic tripeptide hemiasterlin with tubulin: comparison with dolastatin 10 and cryptophycin 1.
Bai R; Durso NA; Sackett DL; Hamel E
Biochemistry; 1999 Oct; 38(43):14302-10. PubMed ID: 10572005
[TBL] [Abstract][Full Text] [Related]
37. Antineoplastic agents 365. Dolastatin 10 SAR probes.
Pettit GR; Srirangam JK; Barkoczy J; Williams MD; Boyd MR; Hamel E; Pettit RK; Hogan F; Bai R; Chapuis JC; McAllister SC; Schmidt JM
Anticancer Drug Des; 1998 Jun; 13(4):243-77. PubMed ID: 9627667
[TBL] [Abstract][Full Text] [Related]
38. Direct photoaffinity labeling by dolastatin 10 of the amino-terminal peptide of beta-tubulin containing cysteine 12.
Bai R; Covell DG; Taylor GF; Kepler JA; Copeland TD; Nguyen NY; Pettit GR; Hamel E
J Biol Chem; 2004 Jul; 279(29):30731-40. PubMed ID: 15123603
[TBL] [Abstract][Full Text] [Related]
39. Natural organic compounds that affect to microtubule functions.
Iwasaki S
Yakugaku Zasshi; 1998 Apr; 118(4):112-26. PubMed ID: 9564789
[TBL] [Abstract][Full Text] [Related]
40. Mechanism of mitotic arrest induced by dolastatin 15 involves loss of tension across kinetochore pairs.
Lopus M
Mol Cell Biochem; 2013 Oct; 382(1-2):93-102. PubMed ID: 23744533
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
